Recorded fact · drug.label_indication
drug.label_indication for cariprazine|schizophrenia
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 3ebc4ad7 resolves to.
The record
| Fact id | 3ebc4ad78b75cbf9b9acd0f7 |
|---|---|
| Entity | drug: cariprazine|schizophrenia |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20251218 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Treatment of schizophrenia in adult and pediatric patients 13 years of age and older [see Clinical Studies ( 14.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: db0bca1aa9b789e02bf05d742a9017d699c689ad4c4513a09b41cac7f86af549.
The value
{
"ingredient": "CARIPRAZINE",
"conditionId": "schizophrenia",
"conditionName": "Schizophrenia",
"matchedAlias": "schizophrenia",
"context": "indication",
"brand": "Vraylar",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "4b5f7c65-aa2d-452a-b3db-bc85c06ff12f",
"labelEffectiveTime": "20251218",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: e8738286c89e406b18cda4f6e31587d562b00ae1d48b2b4a5b4e27b729a37a14.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.